Intelligent Population Health Reporting
through Oberoi Disease Management
Hormone Replacement Therapy (HRT)
The menopause affects all women and can have significant consequences both on impact of symptoms and later health problems.
The menopause affects all women and can have significant consequences both on impact of symptoms and later health problems.
The Oberoi Disease Management HRT module is aligned to the NICE guideline (NG23) Menopause: Diagnosis and Management and is designed to enable primary care organisations to identify, intervene and positively impact the lives of women during peri and post menopause.
The Service Supports Healthcare Organisations (HCOs) to:
Understand the different types of HRT
Estrogen-only, Combined Estrogen-Progesterone, and Low-Dose Eestosterone
Optimise Medication
For patients that may benefit from HRT or a review of their current therapy
Patient Safety
Ensuring HRT regimens are appropriate according to guidelines
Dashboards
Our dashboards align seamlessly with the NHS organisational structure and are available at practice, PCN and ICB level, enabling benchmarking, easy comparison and tracking of key performance indicators.
With this alignment, our dashboard empowers PCNs and ICS to optimise care coordination, drive efficiency, and deliver patient-centered care. Providers can identify variations, share best practices, and drive resource allocation.
